)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Sandu Pharmaceuticals
Sandu Pharmaceuticals (524703) investor relations material
Sandu Pharmaceuticals Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 25/26 earnings summary5 May, 2026
Executive summary
Standalone audited financial results for the quarter and year ended 31st March 2026 were approved and published, with an unmodified audit opinion from the statutory auditors.
Final dividend of Rs. 1 per equity share (10% of face value) recommended for FY 2025-26, subject to shareholder approval.
Board approved reappointment of cost and internal auditors for FY 2026-27.
Financial highlights
Revenue from operations for Q4 FY26 was Rs. 1,685.34 lakhs, up from Rs. 1,406.92 lakhs in Q4 FY25.
Net profit for Q4 FY26 stood at Rs. 97.51 lakhs, compared to Rs. 32.64 lakhs in Q4 FY25.
For the full year FY26, revenue was Rs. 6,993.45 lakhs (FY25: Rs. 6,719.24 lakhs), and net profit was Rs. 176.61 lakhs (FY25: Rs. 154.89 lakhs).
Total comprehensive income for FY26 was Rs. 242.95 lakhs, up from Rs. 219.47 lakhs in FY25.
Earnings per share (EPS) for FY26 was Rs. 1.83, compared to Rs. 1.60 in FY25.
Outlook and guidance
Board and management continue to focus on core Ayurvedic medicines segment, with no indication of diversification.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sandu Pharmaceuticals
- Q3 FY26 saw higher revenue and profit, with EPS at ₹1.01 and a single-segment focus.524703
Q3 25/266 Feb 2026 - Revenue and profit grew modestly; subsidiary wound up; cash reserves increased.524703Q2 24/2519 Nov 2025
- Q1 FY25 saw revenue rise to ₹1,704.54 lakhs and a recommended dividend of ₹0.80 per share.524703Q1 24/2519 Nov 2025
- Stable financial performance with steady revenue, profit, and no new borrowings or equity changes.524703Q4 23/2419 Nov 2025
- Q2 FY26 saw higher revenue, improved profit, and robust cash flow in Ayurvedic medicines.524703Q2 25/2612 Nov 2025
- Q1 FY26 saw higher revenue and profit, with AGM and dividend record date set for September.524703Q1 25/2613 Aug 2025
- FY25 saw steady profit growth, a dividend proposal, and a shift to standalone reporting.524703Q4 24/2516 Jun 2025
- Q3 FY25 net profit more than doubled year-over-year as Sandu shifts to standalone reporting.524703Q3 24/256 Jun 2025
Next Sandu Pharmaceuticals earnings date
Q1 26/2712 Aug, 2026
Sandu Pharmaceuticals
Next Sandu Pharmaceuticals earnings date
Q1 26/2712 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage